Novel activities of CYP11A1 and their potential physiological significance

Journal of Steroid Biochemistry and Molecular Biology

Volumn 151, Issue , 2015, Pages 25-37

  Slominski, Andrzej T ^a   Li, Wei ^a   Kim, Tae Kang ^a   Semak, Igor ^b   Wang, Jin ^a   Zjawiony, Jordan K ^c   Tuckey, Robert C ^d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b BELARUSIAN STATE UNIVERSITY   (Belarus)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

7 Dehydrocholesterol; Cholesterol; CYP11A1; Ergosterol; Plant sterols; Vitamin D

Indexed keywords

7 DEHYDROCHOLESTEROL; 7-DEHYDROCHOLESTEROL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); COLECALCIFEROL; ERGOCALCIFEROL; STEROL;

ANIMAL; HUMAN; METABOLISM;

ANIMALS; CHOLECALCIFEROL; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; DEHYDROCHOLESTEROLS; ERGOCALCIFEROLS; HUMANS; STEROLS;

EID: 84964697415     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.11.010     Document Type: Review

References (124)

1. [1] Tuckey, R.C., Progesterone synthesis by the human placenta. Placenta 26 (2005), 273–281.
2. [2] Miller, W.L., Auchus, R.J., The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32 (2011), 81–151.
3. [3] Burstein, S., Middleditch, B.S., Gut, M., Mass spectrometric study of the enzymatic conversion of cholesterol to (22R)-22-hydroxycholesterol, (20R,22R)-20,22-dihydroxycholesterol, and pregnenolone, and of (22R)-22-hydroxycholesterol to the lgycol and pregnenolone in bovine adrenocortical preparations. Mode of oxygen incorporation. J. Biol. Chem. 250 (1975), 9028–9037.
4. [4] Miller, W.L., Molecular biology of steroid hormone synthesis. Endocr. Rev. 9 (1988), 295–318.
5. [5] Lambeth, J.D., Seybert, D.W., Lancaster, J.R. Jr., Salerno, J.C., Kamin, H., Steroidogenic electron transport in adrenal cortex mitochondria. Mol. Cell. Biochem. 45 (1982), 13–31.
6. [6] Mast, N., Annalora, A.J., Lodowski, D.T., Palczewski, K., Stout, C.D., Pikuleva, I.A., Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J. Biol. Chem. 286 (2011), 5607–5613.
7. [7] Strushkevich, N., MacKenzie, F., Cherkesova, T., Grabovec, I., Usanov, S., Park, H.W., Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10139–10143.
8. [8] Slominski, A.T., Kim, T.K., Chen, J., Nguyen, M.N., Li, W., Yates, C.R., Sweatman, T., Janjetovic, Z., Tuckey, R.C., Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes. Int. J. Biochem. Cell Biol. 44 (2012), 2003–2018.
9. [9] Slominski, A.T., Kim, T.K., Shehabi, H.Z., Tang, E.K., Benson, H.A., Semak, I., Lin, Z., Yates, C.R., Wang, J., Li, W., Tuckey, R.C., In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes Caco-2 colon cells and the adrenal gland. Mol. Cell. Endocrinol. 383 (2014), 181–192.
10. [10] Tuckey, R.C., Nguyen, M.N., Chen, J., Slominski, A.T., Baldisseri, D.M., Tieu, E.W., Zjawiony, J.K., Li, W., Human cytochrome P450scc (CYP11A1) catalyzes epoxide formation with ergosterol. Drug Metab. Dispos. 40 (2012), 436–444.
11. [11] Miller, W.L., Bose, H.S., Early steps in steroidogenesis: intracellular cholesterol trafficking. J. Lipid Res. 52 (2011), 2111–2135.
12. [12] Miller, W.L., Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochim. Biophys. Acta 1771 (2007), 663–676.
13. [13] Hu, J., Zhang, Z., Shen, W.J., Azhar, S., Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr. Metab. (Lond.), 7, 2010, 47.
14. [14] Slominski, A., Zjawiony, J., Wortsman, J., Semak, I., Stewart, J., Pisarchik, A., Sweatman, T., Marcos, J., Dunbar, C., Tuckey, R.C., A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur. J. Biochem. 271 (2004), 4178–4188.
15. [15] Slominski, A., Zbytek, B., Nikolakis, G., Manna, P.R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C.C., Tuckey, R.C., Steroidogenesis in the skin: implications for local immune functions. J. Steroid Biochem. Mol. Biol. 137 (2013), 107–123.
16. [16] Arthur, J.R., Blair, H.A., Boyd, G.S., Mason, J.I., Suckling, K.E., Oxidation of cholesterol and cholesterol analogues by mitochondrial preparations of steroid-hormone-producing tissue. Biochem. J. 158 (1976), 47–51.
17. [17] Mason, J.I., Arthur, J.R., Boyd, G.S., Control of sterol metabolism in rat adrenal mitochondria. Biochem. J. 174 (1978), 1045–1051.
18. [18] Craig, I.F., Mason, J.I., Suckling, K.E., Boyd, G.S., The influence of the side chain on sterol side-chain cleavage in rat adrenal glands. Biochim. Biophys. Acta 711 (1982), 123–127.
19. [19] Morisaki, M., Duque, C., Ikekawa, N., Shikita, M., Substrate specificity of adrenocortical cytochrome P-450scc–I. Effect of structural modification of cholesterol side-chain on pregnenolone production. J. Steroid Biochem. 13 (1980), 545–550.
20. [20] Mason, J.I., Arunachalam, T., Caspi, E., In vitro studies of the adrenal metabolism of halogenated side-chain analogues of cholesterol. Biochim. Biophys. Acta 752 (1983), 265–276.
21. [21] Lambeth, J.D., Cytochrome P-450scc a review of the specificity and properties of the cholesterol binding site. Endocr. Res. 12 (1986), 371–392.
22. [22] Guryev, O., Carvalho, R.A., Usanov, S., Gilep, A., Estabrook, R.W., A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 14754–14759.
23. [23] Slominski, A.T., Zmijewski, M.A., Semak, I., Sweatman, T., Janjetovic, Z., Li, W., Zjawiony, J.K., Tuckey, R.C., Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin. PLoS ONE, 4, 2009, e4309.
24. [24] Slominski, A., Semak, I., Zjawiony, J., Wortsman, J., Li, W., Szczesniewski, A., Tuckey, R.C., The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J. 272 (2005), 4080–4090.
25. [25] Tuckey, R.C., Li, W., Zjawiony, J.K., Zmijewski, M.A., Nguyen, M.N., Sweatman, T., Miller, D., Slominski, A., Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J. 275 (2008), 2585–2596.
26. [26] Tuckey, R.C., Li, W., Shehabi, H.Z., Janjetovic, Z., Nguyen, M.N., Kim, T.K., Chen, J., Howell, D.E., Benson, H.A., Sweatman, T., Baldisseri, D.M., Slominski, A., Production of 22-hydroxy-metabolites of vitamin D3 by cytochrome P450scc (CYP11A1) and analysis of their biological activities on skin cells. Drug Metab. Dispos. 39 (2011), 1577–1588.
27. [27] Slominski, A.T., Kim, T.K., Shehabi, H.Z., Semak, I., Tang, E.K., Nguyen, M.N., Benson, H.A., Korik, E., Janjetovic, Z., Chen, J., Yates, C.R., Postlethwaite, A., Li, W., Tuckey, R.C., In vivo evidence for a novel pathway of vitamin D(3) metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 26 (2012), 3901–3915.
28. [28] Nguyen, M.N., Slominski, A., Li, W., Ng, Y.R., Tuckey, R.C., Metabolism of vitamin D2–17,20,24-trihydroxyvitamin D2 by cytochrome p450scc (CYP11A1). Drug Metab. Dispos. 37 (2009), 761–767.
29. [29] Slominski, A., Semak, I., Wortsman, J., Zjawiony, J., Li, W., Zbytek, B., Tuckey, R.C., An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J. 273 (2006), 2891–2901.
30. [30] Slominski, A., Semak, I., Zjawiony, J., Wortsman, J., Gandy, M.N., Li, J., Zbytek, B., Li, W., Tuckey, R.C., Enzymatic metabolism of ergosterol by cytochrome p450scc to biologically active 17alpha,24-dihydroxyergosterol. Chem. Biol. 12 (2005), 931–939.
31. [31] Tuckey, R.C., Slominski, A.T., Cheng, C.Y., Chen, J., Kim, T.K., Xiao, M., Li, W., Lumisterol is metabolized by CYP11A1: discovery of a new pathway. Int. J. Biochem. Cell Biol. 55 (2014), 24–34.
32. [32] John, M.E., John, M.C., Ashley, P., MacDonald, R.J., Simpson, E.R., Waterman, M.R., Identification and characterization of cDNA clones specific for cholesterol side-chain cleavage cytochrome P-450. Proc. Natl. Acad. Sci. U. S. A. 81 (1984), 5628–5632.
33. [33] Kazeto, Y., Ijiri, S., Adachi, S., Yamauchi, K., Cloning and characterization of a cDNA encoding cholesterol side-chain cleavage cytochrome P450 (CYP11A1): tissue-distribution and changes in the transcript abundance in ovarian tissue of Japanese eel Anguilla japonica, during artificially induced sexual development. J. Steroid Biochem. Mol. Biol. 99 (2006), 121–128.
34. [34] Nunez, S., Trant, J.M., Isolation of the putative cDNA encoding cholesterol side chain cleavage cytochrome P450 (CYP11A) of the southern stingray (Dasyatis americana). Gene 187 (1997), 123–129.
35. [35] Usanov, S.A., Graham, S.E., Lepesheva, G.I., Azeva, T.N., Strushkevich, N.V., Gilep, A.A., Estabrook, R.W., Peterson, J.A., Probing the interaction of bovine cytochrome P450scc (CYP11A1) with adrenodoxin: evaluating site-directed mutations by molecular modeling. Biochemistry 41 (2002), 8310–8320.
36. [36] Tuls, J., Geren, L., Millett, F., Fluorescein isothiocyanate specifically modifies lysine 338 of cytochrome P-450scc and inhibits adrenodoxin binding. J. Biol. Chem. 264 (1989), 16421–16425.
37. [37] Wada, A., Waterman, M.R., Identification by site-directed mutagenesis of two lysine residues in cholesterol side chain cleavage cytochrome P450 that are essential for adrenodoxin binding. J. Biol. Chem. 267 (1992), 22877–22882.
38. [38] Nakamoto, M., Fukasawa, M., Orii, S., Shimamori, K., Maeda, T., Suzuki, A., Matsuda, M., Kobayashi, T., Nagahama, Y., Shibata, N., Cloning and expression of medaka cholesterol side chain cleavage cytochrome P450 during gonadal development. Dev. Growth Differ. 52 (2010), 385–395.
39. [39] Storbeck, K.H., Swart, P., Graham, S., Swart, A.C., The influence of the amino acid substitution I98K on the catalytic activity of baboon cytochrome P450 side-chain cleavage (CYP11A1). Endocr. Res. 30 (2004), 761–767.
40. [40] Okuyama, E., Okazaki, T., Furukawa, A., Wu, R.F., Ichikawa, Y., Molecular cloning and nucleotide sequences of cDNA clones of sheep and goat adrenocortical cytochromes P450scc (CYP11A1). J. Steroid Biochem. Mol. Biol. 57 (1996), 179–185.
41. [41] Vilchis, F., Chavez, B., Larrea, F., Timossi, C., Montiel, F., The cDNA cloning and tissue expression of the cytochrome P450scc from Syrian hamster (Mesocricetus auratus). Gen. Comp. Endocrinol. 126 (2002), 279–286.
42. [42] Chung, B.C., Matteson, K.J., Voutilainen, R., Mohandas, T.K., Miller, W.L., Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15 and expression in the placenta. Proc. Natl. Acad. Sci. U. S. A. 83 (1986), 8962–8966.
43. [43] Lai, W.W., Hsiao, P.H., Guiguen, Y., Chung, B.C., Cloning of zebrafish cDNA for 3beta-hydroxysteroid dehydrogenase and P450scc. Endocr. Res. 24 (1998), 927–931.
44. [44] Parajes, S., Griffin, A., Taylor, A.E., Rose, I.T., Miguel-Escalada, I., Hadzhiev, Y., Arlt, W., Shackleton, C., Muller, F., Krone, N., Redefining the initiation and maintenance of zebrafish interrenal steroidogenesis by characterizing the key enzyme cyp11a2. Endocrinology 154 (2013), 2702–2711.
45. [45] Gilman, C.I., Leusch, F.D., Breckenridge, W.C., MacLatchy, D.L., Effects of a phytosterol mixture on male fish plasma lipoprotein fractions and testis P450scc activity. Gen. Comp. Endocrinol. 130 (2003), 172–184.
46. [46] Takahashi, M., Tanaka, M., Sakai, N., Adachi, S., Miller, W.L., Nagahama, Y., Rainbow trout ovarian cholesterol side-chain cleavage cytochrome P450 (P450scc). cDNA cloning and mRNA expression during oogenesis. FEBS Lett. 319 (1993), 45–48.
47. [47] Nomura, O., Nakabayashi, O., Nishimori, K., Mizuno, S., The cDNA cloning and transient expression of a chicken gene encoding cytochrome P-450scc. Gene 185 (1997), 217–222.
48. [48] Tuckey, R.C., Cameron, K.J., Side-chain specificities of human and bovine cytochromes P-450scc. Eur. J. Biochem. 217 (1993), 209–215.
49. [49] Tuckey, R.C., Cameron, K.J., Catalytic properties of cytochrome P-450scc purified from the human placenta: comparison to bovine cytochrome P-450scc. Biochim. Biophys. Acta 1163 (1993), 185–194.
50. [50] Frantz, I.D. Jr., Schroepfer, G.J. Jr., Sterol biosynthesis. Annu. Rev. Biochem. 36 (1967), 691–726.
51. [51] Porter, F.D., Malformation syndromes due to inborn errors of cholesterol synthesis. J. Clin. Invest. 110 (2002), 715–724.
52. [52] Gaylor, J.L., Membrane-bound enzymes of cholesterol synthesis from lanosterol. Biochem. Biophys. Res. Commun. 292 (2002), 1139–1146.
53. [53] Waterham, H.R., Wanders, R.J., Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome. Biochim. Biophys. Acta 1529 (2000), 340–356.
54. [54] Bae, S.H., Paik, Y.K., Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol delta 24-reductase. Biochem. J. 326:Pt 2 (1997), 609–616.
55. [55] Porter, F.D., Herman, G.E., Malformation syndromes caused by disorders of cholesterol synthesis. J. Lipid Res. 52 (2011), 6–34.
56. [56] Zmijewski, M.A., Li, W., Zjawiony, J.K., Sweatman, T.W., Chen, J., Miller, D.D., Slominski, A.T., Synthesis and photo-conversion of androsta- and pregna-5,7-dienes to vitamin D3-like derivatives. Photochem. Photobiol. Sci. 7 (2008), 1570–1576.
57. [57] Slominski, A., Kim, T.K., Zmijewski, M.A., Janjetovic, Z., Li, W., Chen, J., Kusniatsova, E.I., Semak, I., Postlethwaite, A., Miller, D.D., Zjawiony, J.K., Tuckey, R.C., Novel vitamin D photoproducts and their precursors in the skin. Dermatoendocrinol 5 (2013), 7–19.
58. [58] Nowaczyk, M.J., Waye, J.S., The Smith-Lemli-Opitz syndrome: a novel metabolic way of understanding developmental biology, embryogenesis, and dysmorphology. Clin. Genet. 59 (2001), 375–386.
59. [59] Tint, G.S., Irons, M., Elias, E.R., Batta, A.K., Frieden, R., Chen, T.S., Salen, G., Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330 (1994), 107–113.
60. [60] Shackleton, C.H., Roitman, E., Kelley, R., Neonatal urinary steroids in Smith-Lemli-Opitz syndrome associated with 7-dehydrocholesterol reductase deficiency. Steroids 64 (1999), 481–490.
61. [61] Shackleton, C.H., Role of a disordered steroid metabolome in the elucidation of sterol and steroid biosynthesis. Lipids 47 (2012), 1–12.
62. [62] Tait, A.D., Hodge, L.C., Allen, W.R., Biosynthesis of 3 beta-hydroxy-5,7-pregnadien-20-one by the horse fetal gonad. FEBS Lett. 153 (1983), 161–164.
63. [63] Marcos, J., Guo, L.W., Wilson, W.K., Porter, F.D., Shackleton, C., The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli-Opitz syndrome) to neurosteroid production. Steroids 69 (2004), 51–60.
64. [64] Shackleton, C., Roitman, E., Guo, L.W., Wilson, W.K., Porter, F.D., Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patients with 7-dehydrosterol-delta7-reductase deficiency (Smith-Lemli-Opitz syndrome). J. Steroid Biochem. Mol. Biol. 82 (2002), 225–232.
65. [65] Sushko, T.A., Gilep, A.A., Yantsevich, A.V., Usanov, S.A., Role of microsomal steroid hydroxylases in Delta7-steroid biosynthesis. Biochemistry (Mosc.) 78 (2013), 282–289.
66. [66] Slominski, A.T., Manna, P.R., Tuckey, R.C., Cutaneous glucocorticosteroidogenesis: securing local homeostasis and the skin integrity. Exp. Dermatol. 23 (2014), 369–374.
67. [67] Slominski, A.T., Zmijewski, M.A., Zbytek, B., Tobin, D.J., Theoharides, T.C., Rivier, J., Key role of CRF in the skin stress response system. Endocr. Rev. 34 (2013), 827–884.
68. [68] Zmijewski, M.A., Li, W., Zjawiony, J.K., Sweatman, T.W., Chen, J., Miller, D.D., Slominski, A.T., Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3 beta, 17 alpha, 20-triol and their bioactivity in melanoma cells. Steroids 74 (2009), 218–228.
69. [69] Slominski, A.T., Zmijewski, M.A., Semak, I., Zbytek, B., Pisarchik, A., Li, W., Zjawiony, J., Tuckey, R.C., Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med. Chem. 14 (2014), 77–96.
70. [70] Strott, C.A., Higashi, Y., Cholesterol sulfate in human physiology: what's it all about?. J. Lipid Res. 44 (2003), 1268–1278.
71. [71] Tuckey, R.C., Lawrence, J., Cameron, K.J., Side-chain cleavage of cholesterol esters by human cytochrome P-450(scc). J. Steroid Biochem. Mol. Biol. 58 (1996), 605–610.
72. [72] Tuckey, R.C., Side-chain cleavage of cholesterol sulfate by ovarian mitochondria. J. Steroid Biochem. Mol. Biol. 37 (1990), 121–127.
73. [73] Harteneck, C., Pregnenolone sulfate: from steroid metabolite to TRP channel ligand. Molecules 18 (2013), 12012–12028.
74. [74] Holick, M.F., MacLaughlin, J.A., Doppelt, S.H., Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science 211 (1981), 590–593.
75. [75] MacLaughlin, J.A., Anderson, R.R., Holick, M.F., Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 216 (1982), 1001–1003.
76. [76] Dixon, K.M., Norman, A.W., Sequeira, V.B., Mohan, R., Rybchyn, M.S., Reeve, V.E., Halliday, G.M., Mason, R.S., 1alpha 25(OH)(2)-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesis. Cancer Prev. Res. (Phila.) 4 (2011), 1485–1494.
77. [77] Slominski, A.T., Janjetovic, Z., Fuller, B.E., Zmijewski, M.A., Tuckey, R.C., Nguyen, M.N., Sweatman, T., Li, W., Zjawiony, J., Miller, D., Chen, T.C., Lozanski, G., Holick, M.F., Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PLoS ONE, 5, 2010, e9907.
78. [78] Russell, D.W., The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72 (2003), 137–174.
79. [79] Spann, N.J., Garmire, L.X., McDonald, J.G., Myers, D.S., Milne, S.B., Shibata, N., Reichart, D., Fox Shaked, J.N. I, Heudobler, D., Raetz, C.R., Wang, E.W., Kelly, S.L., Sullards, M.C., Murphy, R.C., Merrill, A.H. Jr., Brown, H.A., Dennis, E.A., Li, A.C., Ley, K., Tsimikas, S., Fahy, E., Subramaniam, S., Quehenberger, O., Russell, D.W., Glass, C.K., Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151 (2012), 138–152.
80. [80] Menon, G.K., Feingold, K.R., Moser, A.H., Brown, B.E., Elias, P.M., De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements. J. Lipid Res. 26 (1985), 418–427.
81. [81] Elias, P.M., Crumrine, D., Paller, A., Rodriguez-Martin, M., Williams, M.L., Pathogenesis of the cutaneous phenotype in inherited disorders of cholesterol metabolism: therapeutic implications for topical treatment of these disorders. Dermatoendocrinol 3 (2011), 100–106.
82. [82] Elias, P.M., Williams, M.L., Feingold, K.R., Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders. Clin. Dermatol. 30 (2012), 311–322.
83. [83] Slominski, A., Ermak, G., Mihm, M., ACTH receptor, CYP11A1CYP17 and CYP21A2 genes are expressed in skin. J. Clin. Endocrinol. Metab. 81 (1996), 2746–2749.
84. [84] Holick, M.F., Clark, M.B., The photobiogenesis and metabolism of vitamin D. Fed. Proc. 37 (1978), 2567–2574.
85. [85] Holick, M.F., Vitamin D: a millenium perspective. J. Cell. Biochem. 88 (2003), 296–307.
86. [86] Holick, M.F., Tian, X.Q., Allen, M., Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 3124–3126.
87. [87] Bikle, D.D., Vitamin D: an ancient hormone. Exp. Dermatol. 20 (2011), 7–13.
88. [88] Zhu, J., DeLuca, H.F., Vitamin D 25-hydroxylase – four decades of searching, are we there yet?. Arch. Biochem. Biophys. 523 (2012), 30–36.
89. [89] Holick, M.F., Holick, S.A., Tavela, T., Gallagher, B., Schnoes, H.K., DeLuca, H.F., Synthesis of (6-3H)-1alpha-hydroxyvitamin D3 and its metabolism in vivo to (3H)-1alpha,25-dihydroxyvitamin D3. Science 190 (1975), 576–578.
90. [90] Cheng, J.B., Levine, M.A., Bell, N.H., Mangelsdorf, D.J., Russell, D.W., Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 7711–7715.
91. [91] Zhu, J., DeLuca, H.F., Vitamin D 25-hydroxylase – four decades of searching, are we there yet?. Arch. Biochem. Biophys. 523 (2012), 30–36.
92. [92] Tieu, E.W., Li, W., Chen, J., Baldisseri, D.M., Slominski, A.T., Tuckey, R.C., Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1. J. Steroid Biochem. 129 (2012), 163–171.
93. [93] Sawada, N., Sakaki, T., Ohta, M., Inouye, K., Metabolism of Vitamin D3 by Human CYP27A1. Biochem. Biophys. Res. Commun. 273 (2000), 977–984.
94. [94] Zehnder, D., Bland, R., Williams, M.C., McNinch, R.W., Howie, A.J., Stewart, P.M., Hewison, M., Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 86 (2001), 888–894.
95. [95] Flanagan, J.N., Wang, L., Tangpricha, V., Reichrath, J., Chen, T.C., Holick, M.F., Regulation of the 25-hydroxyvitamin D-1alpha-hydroxylase gene and its splice variant. Recent Results Cancer Res. 164 (2003), 157–167.
96. [96] Wang, L., Whitlatch, L.W., Flanagan, J.N., Holick, M.F., Chen, T.C., Vitamin D autocrine system and prostate cancer. Recent Results Cancer Res. 164 (2003), 223–237.
97. [97] Cheng, J.B., Motola, D.L., Mangelsdorf, D.J., Russell, D.W., De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J. Biol. Chem. 278 (2003), 38084–38093.
98. [98] Bikle, D.D., Nemanic, M.K., Gee, E., Elias, P., 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J. Clin. Invest. 78 (1986), 557–566.
99. [99] Lehmann, B., Sauter, W., Knuschke, P., Dressler, S., Meurer, M., Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch. Dermatol. Res. 295 (2003), 24–28.
100. [100] Sakaki, T., Kagawa, N., Yamamoto, K., Inouye, K., Metabolism of vitamin D3 by cytochromes P450. Front. Biosci. 10 (2005), 119–134.
101. [101] Prosser, D.E., Jones, G., Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 29 (2004), 664–673.
102. [102] Tieu, E.W., Tang, E.K., Tuckey, R.C., Kinetic analysis of human CYP24A1 metabolism of vitamin D via the C24-oxidation pathway. FEBS J. 281 (2014), 3280–3296.
103. [103] Slominski, A.T., Kim Li, T.K.W., Yi, A.K., Postlethwaite, A., Tuckey, R.C., The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J. Steroid Biochem. Mol. Biol. 144PA (2014), 28–39.
104. [104] Li, W., Chen, J., Janjetovic, Z., Kim, T.K., Sweatman, T., Lu, Y., Zjawiony, J., Tuckey, R.C., Miller, D., Slominski, A., Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity. Steroids 75 (2010), 926–935.
105. [105] Tuckey, R.C., Li, W., Shehabi, H.Z., Janjetovic, Z., Nguyen, M.N., Kim, T.K., Chen, J., Howell, D.E., Benson, H.A., Sweatman, T., Baldisseri, D.M., Slominski, A., Production of 22-hydroxy metabolites of vitamin D3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells. Drug Metab. Dispos. 39 (2011), 1577–1588.
106. [106] Tuckey, R.C., Janjetovic, Z., Li, W., Nguyen, M.N., Zmijewski, M.A., Zjawiony, J., Slominski, A., Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 112 (2008), 213–219.
107. [107] Tieu, E.W., Li, W., Chen, J., Baldisseri, D.M., Slominski, A.T., Tuckey, R.C., Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1. J. Steroid Biochem. Mol. Biol. 129 (2012), 163–171.
108. [108] Tieu, E.W., Tang, E.K., Chen, J., Li, W., Nguyen, M.N., Janjetovic, Z., Slominski, A., Tuckey, R.C., Rat CYP24A1 acts on 20-hydroxyvitamin D(3) producing hydroxylated products with increased biological activity. Biochem. Pharmacol. 84 (2012), 1696–1704.
109. [109] Tang, E.K., Chen, J., Janjetovic, Z., Tieu, E.W., Slominski, A.T., Li, W., Tuckey, R.C., Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1. Drug Metab. Dispos. 41 (2013), 1112–1124.
110. [110] Tang, E.K., Li, W., Janjetovic, Z., Nguyen, M.N., Wang, Z., Slominski, A., Tuckey, R.C., Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity. Drug Metab. Dispos. 38 (2010), 1553–1559.
111. [111] Sidler, D., Renzulli, P., Schnoz, C., Berger, B., Schneider-Jakob, S., Fluck, C., Inderbitzin, D., Corazza, N., Candinas, D., Brunner, T., Colon cancer cells produce immunoregulatory glucocorticoids. Oncogene 30 (2011), 2411–2419.
112. [112] Slominski, A.T., Kim, T.K., Janjetovic, Z., Tuckey, R.C., Bieniek, R., Yue, J., Li, W., Chen, J., Nguyen, M.N., Tang, E.K., Miller, D., Chen, T.C., Holick, M., 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. Am. J. Physiol. Cell Physiol. 300 (2011), C526–541.
113. [113] Taves, M.D., Gomez-Sanchez, C.E., Soma, K.K., Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E11–24.
114. [114] Zbytek, B., Janjetovic, Z., Tuckey, R.C., Zmijewski, M.A., Sweatman, T.W., Jones, E., Nguyen, M.N., Slominski, A.T., 20-Hydroxyvitamin D3 a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J. Invest. Dermatol. 128 (2008), 2271–2280.
115. [115] Janjetovic, Z., Zmijewski, M.A., Tuckey, R.C., DeLeon, D.A., Nguyen, M.N., Pfeffer, L.M., Slominski, A.T., 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS ONE, 4, 2009, e5988.
116. [116] Janjetovic, Z., Tuckey, R.C., Nguyen, M.N., Thorpe, E.M. Jr., Slominski, A.T., 20,23-Dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J. Cell. Phys. 223 (2010), 36–48.
117. [117] Slominski, A.T., Li, W., Bhattacharya, S.K., Smith, R.A., Johnson, P.L., Chen, J., Nelson, K.E., Tuckey, R.C., Miller, D., Jiao, Y., Gu, W., Postlethwaite, A.E., Vitamin D analogs 17,20S(OH) 2pD and 17,20R(OH) 2pD are noncalcemic and exhibit antifibrotic activity. J. Invest. Dermatol. 131 (2011), 1167–1169.
118. [118] Slominski, A., Janjetovic, Z., Tuckey, R.C., Nguyen, M.N., Bhattacharya, K.G., Wang, J., Li, W., Jiao, Y., Gu, W., Brown, M., Postlethwaite, A.E., 20S-Hydroxyvitamin D3 noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo. J. Clin. Endocrinol. Metab. 98 (2013), E298–303.
119. [119] Slominski, A.T., Janjetovic, Z., Kim, T.K., Wright, A.C., Grese, L.N., Riney, S.J., Nguyen, M.N., Tuckey, R.C., Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes. Anticancer Res. 32 (2012), 3733–3742.
120. [120] Wang, J., Slominski, A., Tuckey, R.C., Janjetovic, Z., Kulkarni, A., Chen, J., Postlethwaite, A.E., Miller, D., Li, W., 20-hydroxyvitamin D inhibits proliferation of cancer cells with high efficacy while being non-toxic. Anticancer Res. 32 (2012), 739–746.
121. [121] Janjetovic, Z., Brozyna, A.A., Tuckey, R.C., Kim, T.K., Nguyen, M.N., Jozwicki, W., Pfeffer, S.R., Pfeffer, L.M., Slominski, A.T., High basal NF-kappaB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives. Brit. J. Cancer 105 (2011), 1874–1884.
122. [122] Kim, T.-K., Wang, J., Janjetovic, Z., Chen, J., Tuckey, R.C., Nguyen, M.N., Tang, E.K.Y., Miller, D., Li, W., Slominski, A.T., Correlation between secosteroid induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength. Mol. Cell. Endocrinol. 361 (2012), 143–152, 10.1016/j.mce.2012.04.001.
123. [123] Slominski, A.T., Kim Takeda, T.K.Y., Janjetovic, Z., Brozyna, A.A., Skobowiat, C., Wang, J., Postlethwaite, A., Li, W., Tuckey, R.C., Jetten, A.M., RORalpha and ROR gamma are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J. 28 (2014), 2775–2789.
124. [124] Chen, J., Slominski, A.T., Miller, D.D., Li, W., Effects of sidechain length and composition on the kinetic conversion and product distribution of vitamin D analogs determined by real-time NMR. Dermatoendocrinol 5 (2013), 142–149.